시장보고서
상품코드
1962255

의료용 인체 통신망 시장 분석 및 예측 : 유형별, 제품 유형별, 서비스별, 기술별, 구성요소별, 용도별, 최종 사용자별, 기기별, 기능별, 도입 형태별(-2035년)

Medical Body Area Network Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Device, Functionality, Deployment

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 349 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 인체 통신망 시장은 2024년 165억 달러로 평가되었고, 2034년까지 502억 달러에 이르고, CAGR은 약 11.8%를 나타낼 것으로 예측됩니다. 의료용 인체 통신망 시장은 웨어러블 기기와 센서에 의한 무선 네트워크를 포함하고 생리 데이터를 실시간으로 모니터링하여 원격 건강 관리를 실현합니다. 이러한 네트워크는 만성 질환 관리 및 노인 관리에 필수적인 지속적인 모니터링 및 데이터 수집을 가능하게 하여 환자 관리를 향상시킵니다. IoT 기술의 진보와 소형화로 의료의 디지털화 진전과 맞춤형 의료 솔루션에 대한 수요 증가를 원동력으로 하여 시장은 성장의 기운이 높아지고 있습니다.

의료용 인체 통신망 시장은 무선 통신 기술의 진보와 원격 환자 모니터링 수요 증가를 배경으로 견고한 성장을 이루고 있습니다. 웨어러블 기기 분야가 성능면에서 주도적 역할을 담당해, 피트니스 트래커나 스마트 워치가 건강 데이터 수집의 요점이 되고 있습니다. 심장 모니터 및 혈당 센서와 같은 임베디드 기기는 성능 측면에서 두 번째로 뛰어난 분야이며, 보다 통합된 건강 모니터링 솔루션으로의 전환을 시사합니다. 건강 모니터링 애플리케이션 및 데이터 분석 플랫폼을 포함한 소프트웨어 분야는 실시간 데이터 처리와 개별화된 의료 인사이트력의 필요성을 반영하여 기세를 늘리고 있습니다. 클라우드 기반 솔루션은 확장성과 기존 의료 시스템 간의 통합 용이성으로 인기가 높아지고 있지만, 데이터 보안을 선호하는 기관을 위한 On-Premise 솔루션도 여전히 중요합니다. 유연성과 관리성의 균형을 이루는 하이브리드 모델은 전략적 선택으로 부상하고 있습니다. 민감한 건강 데이터를 보호하기 위한 사이버 보안 대책에 대한 투자는 필수적이며, 이는 시장의 추가 확대를 촉진하고 있습니다.

시장 세분화
유형 웨어러블 기기, 이식형 기기, 복용형 기기
제품 센서, 모니터, 송신기, 수신기
서비스 원격 모니터링, 컨설팅 서비스, 유지 보수 서비스, 통합 서비스
기술 Bluetooth, Wi-Fi, Zigbee, 초광대역
구성요소 마이크로컨트롤러, 메모리 칩, 아날로그 부품, 전원 관리 유닛
신청 만성 질환 관리, 피트니스 모니터링, 원격 환자 모니터링, 급성기 사후 관리 모니터링
최종 사용자 병원, 외래수술센터(ASC), 재택치료 시설, 연구 기관
장치 심전도 모니터링 장치, 혈압계, 혈당 모니터링 장치, 산소포화도 측정기
기능 실시간 모니터링, 데이터 기록, 경고 및 알림, 데이터 분석
도입 형태 On-Premise, 클라우드 기반, 하이브리드

의료용 인체 통신망 시장은 다양한 신제품 투입과 경쟁력 있는 가격 전략을 특징으로 하는 역동적인 변화를 경험하고 있습니다. 주요 기업은 첨단 의료 모니터링 시스템에 대한 수요 증가에 부응하는 혁신적인 솔루션을 도입하여 제품 포트폴리오를 확대하고 있습니다. 이 진화는 기술 진보와 지속적인 건강 모니터링이 필요한 만성 질환 증가에 의해 추진되고 있습니다. 시장에서는 제품 제공 강화와 세계 전개 확대를 목적으로 한 전략적 제휴와 협업이 급증하고 있습니다. 의료용 인체 통신망 시장에서의 경쟁은 격화되고 있으며, 주요 기업은 기술 혁신과 전략적 제휴를 통해 경쟁 우위를 확립하기 위해 노력하고 있습니다. 규제의 영향, 특히 북미와 유럽의 규제는 제품의 안전성과 효능을 보장하는 기준을 시행하고 시장 역학을 형성하는데 있어 매우 중요한 역할을 합니다. 경쟁업체와의 비교 분석을 통해 연구개발 투자와 인공지능의 통합을 통한 기기 기능 강화에 중점을 두고 있음이 분명합니다. 시장 전망은 견고하고 신흥 시장과 원격 의료 솔루션의 보급 확대가 성장 기회를 견인하고 있습니다.

주요 동향과 촉진요인

의료용 인체 통신망 시장은 기술 진보와 의료 요구에 견인되어 변혁기를 맞이하고 있습니다. 주요 동향 중 하나는 IoT와 웨어러블 기술의 통합이며 환자 모니터링에 혁명을 일으키고 있습니다. 이러한 혁신으로 실시간 데이터 수집·분석이 가능해져 의료 현장에서의 환자 케어와 업무 효율이 향상되고 있습니다. 원격 의료도 주요 촉진요인이며 세계의 유행에 의해 가속되었습니다. 이로 인해 의료 제공의 형태가 재구성되어 원격 모니터링과 환자 참여가 그 어느 때보다 중요합니다. 이러한 변화는 환자와 의료 제공업체 간의 원활한 의사 소통을 가능하게하는 신체 영역 네트워크의 도입을 지원합니다. 세계의 고령화도 중요한 촉진요인입니다. 평균 수명이 연장됨에 따라 지속적인 건강 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 이 인구 역학의 동향은 신뢰성 있고 비침습적인 건강 추적을 가능하게 하는 첨단 의료용 인체 통신망 수요를 촉진하고 있습니다. 게다가 디지털 헬스 솔루션을 추진하는 규제면의 지원과 대처가 시장 성장을 가속하고 있습니다. 정부와 의료기관은 의료에 대한 접근성과 질을 향상시키는 기술을 점점 더 지지하고 있습니다. 마지막으로 만성 질환의 유병률 상승은 효율적인 모니터링 시스템을 필요로 하고 의료용 인체 통신망 시장은 크게 확대될 것으로 전망됩니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

  • 거시경제 분석
  • 시장 동향
  • 시장 성장 촉진요인
  • 시장 기회
  • 시장 성장 억제요인
  • CAGR : 성장 분석
  • 영향 분석
  • 신흥 시장
  • 기술 로드맵
  • 전략적 프레임워크

제4장 부문 분석

  • 시장 규모 및 예측 : 유형별
    • 웨어러블 기기
    • 이식형 기기
    • 복용형 기기
  • 시장 규모 및 예측 : 제품별
    • 센서
    • 모니터
    • 송신기
    • 수신기
  • 시장 규모 및 예측 : 서비스별
    • 원격 모니터링
    • 컨설팅 서비스
    • 유지보수 서비스
    • 통합서비스
  • 시장 규모 및 예측 : 기술별
    • Bluetooth
    • Wi-Fi
    • Zigbee
    • 초광대역
  • 시장 규모 및 예측 : 구성요소별
    • 마이크로컨트롤러
    • 메모리 칩
    • 아날로그 부품
    • 전원 관리 유닛
  • 시장 규모 및 예측 : 용도별
    • 만성 질환 관리
    • 피트니스 모니터링
    • 원격 환자 모니터링
    • 급성기 사후 관리 모니터링
  • 시장 규모 및 예측 : 최종사용자별
    • 병원
    • 외래수술센터(ASC)
    • 재택치료 환경
    • 연구기관
  • 시장 규모 및 예측 : 기기별
    • 심전도 모니터링 장치
    • 혈압계
    • 혈당 모니터링 장치
    • 산소포화도 측정기
  • 시장 규모 및 예측 : 기능별
    • 실시간 모니터링
    • 데이터 로깅
    • 알람 및 알림
    • 데이터 분석
  • 시장 규모 및 예측 : 전개별
    • On-Premise
    • 클라우드 기반
    • 하이브리드

제5장 지역별 분석

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카
  • 아시아태평양
    • 중국
    • 인도
    • 한국
    • 일본
    • 호주
    • 대만
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 사하라 이남 아프리카
    • 기타 중동 및 아프리카

제6장 시장 전략

  • 수요 및 공급 격차 분석
  • 무역 및 물류상의 제약
  • 가격-비용-마진 추세
  • 시장 침투
  • 소비자 분석
  • 규제 개요

제7장 경쟁 정보

  • 시장 포지셔닝
  • 시장 점유율
  • 경쟁 벤치마킹
  • 주요 기업의 전략

제8장 기업 프로파일

  • Biotronik
  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Fujifilm Holdings
  • Johnson Johnson Medical Devices
  • Stryker
  • Zimmer Biomet
  • Smith Nephew
  • Baxter International
  • Becton Dickinson
  • Integra Life Sciences
  • Hill-Rom Holdings
  • Terumo Corporation
  • Cardinal Health
  • Cook Medical
  • Nihon Kohden

제9장 당사에 대해서

SHW

Medical Body Area Network Market is anticipated to expand from $16.5 billion in 2024 to $50.2 billion by 2034, growing at a CAGR of approximately 11.8%. The Medical Body Area Network Market encompasses wireless networks of wearable devices and sensors that monitor physiological data in real-time, facilitating remote health management. These networks enhance patient care by enabling continuous monitoring and data collection, crucial for chronic disease management and elderly care. With advancements in IoT and miniaturization, the market is poised for growth, driven by increasing healthcare digitization and demand for personalized medicine solutions.

The Medical Body Area Network Market is experiencing robust growth, fueled by advances in wireless communication technologies and increasing demand for remote patient monitoring. The wearable devices segment leads in performance, with fitness trackers and smartwatches being pivotal in health data collection. Implantable devices, such as cardiac monitors and glucose sensors, are the second highest performing segment, indicating a shift towards more integrated health monitoring solutions. The software segment, including health monitoring applications and data analytics platforms, is gaining momentum, reflecting the need for real-time data processing and personalized healthcare insights. Cloud-based solutions are becoming increasingly popular due to their scalability and ease of integration with existing healthcare systems, while on-premise solutions maintain relevance for institutions prioritizing data security. Hybrid models are emerging as a strategic choice, balancing flexibility with control. Investments in cybersecurity measures are essential to protect sensitive health data, further driving market expansion.

Market Segmentation
TypeWearable Devices, Implantable Devices, Ingestible Devices
ProductSensors, Monitors, Transmitters, Receivers
ServicesRemote Monitoring, Consultation Services, Maintenance Services, Integration Services
TechnologyBluetooth, Wi-Fi, Zigbee, Ultra-Wideband
ComponentMicrocontrollers, Memory Chips, Analog Components, Power Management Units
ApplicationChronic Disease Management, Fitness Monitoring, Remote Patient Monitoring, Post-Acute Care Monitoring
End UserHospitals, Ambulatory Surgical Centers, Home Care Settings, Research Institutes
DeviceECG Monitoring Devices, Blood Pressure Monitors, Glucose Monitoring Devices, Pulse Oximeters
FunctionalityReal-Time Monitoring, Data Logging, Alerts and Notifications, Data Analysis
DeploymentOn-Premises, Cloud-Based, Hybrid

The Medical Body Area Network market is experiencing a dynamic shift, characterized by a diverse array of new product launches and competitive pricing strategies. Leading companies are expanding their portfolios, introducing innovative solutions that cater to the growing demand for advanced healthcare monitoring systems. This evolution is driven by technological advancements and the increasing prevalence of chronic diseases, which necessitate continuous health monitoring. The market is witnessing a surge in strategic partnerships and collaborations, aimed at enhancing product offerings and expanding global reach. Competition in the Medical Body Area Network market is intensifying, with key players striving to establish a competitive edge through technological innovation and strategic alliances. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, enforcing standards that ensure product safety and efficacy. Benchmarking against competitors reveals a focus on R&D investment and the integration of artificial intelligence to enhance device functionality. The market outlook remains robust, with opportunities for growth driven by emerging markets and the increasing adoption of telemedicine solutions.

Tariff Impact:

The Medical Body Area Network Market is intricately influenced by global tariffs, geopolitical dynamics, and evolving supply chain frameworks. Japan and South Korea are increasingly focusing on self-reliance in medical technology components to mitigate tariff-induced costs and geopolitical uncertainties. China is accelerating its domestic innovation in wearable health technologies, driven by export restrictions and a strategic pivot towards self-sufficiency. Taiwan, pivotal in semiconductor supply, faces geopolitical risks, yet remains indispensable to global supply chains. The parent market, encompassing digital health solutions, is witnessing robust growth, driven by aging populations and technological advancements. By 2035, the market's evolution will hinge on resilient supply chains and strategic regional collaborations. Middle East conflicts continue to exert pressure on energy prices, indirectly affecting global manufacturing and distribution costs.

Geographical Overview:

The Medical Body Area Network (MBAN) market is witnessing notable expansion across diverse regions, each demonstrating unique growth dynamics. North America leads the charge, propelled by advanced healthcare infrastructure and significant investments in wearable medical technology. The region's focus on digital health innovation and chronic disease management further accelerates market growth. Europe follows with robust investments in healthcare technology and a strong regulatory framework supporting MBAN adoption. The region's emphasis on patient-centric care and telemedicine enhances its market potential. In Asia Pacific, the MBAN market is rapidly growing, driven by increasing healthcare expenditure and technological advancements. Emerging economies such as China and India are investing heavily in digital health solutions. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, rising healthcare awareness and infrastructure development are key drivers. Meanwhile, the Middle East & Africa are recognizing the transformative potential of MBAN in improving healthcare access and outcomes.

Key Trends and Drivers:

The Medical Body Area Network Market is experiencing a transformative phase driven by technological advancements and healthcare demands. One key trend is the integration of IoT and wearable technology, which is revolutionizing patient monitoring. These innovations enable real-time data collection and analysis, enhancing patient care and operational efficiency in healthcare settings. Telemedicine is another major driver, accelerated by the global pandemic. It has reshaped healthcare delivery, making remote monitoring and patient engagement more crucial than ever. This shift supports the adoption of body area networks, facilitating seamless communication between patients and healthcare providers. The aging global population is also a significant driver. As life expectancy increases, there is a growing need for continuous health monitoring solutions. This demographic trend fuels demand for advanced medical body area networks that can provide reliable and non-invasive health tracking. Moreover, regulatory support and initiatives promoting digital health solutions are propelling market growth. Governments and healthcare organizations are increasingly endorsing technologies that improve healthcare accessibility and quality. Lastly, the rising prevalence of chronic diseases necessitates efficient monitoring systems, positioning the Medical Body Area Network Market for substantial expansion.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Device
  • 2.9 Key Market Highlights by Functionality
  • 2.10 Key Market Highlights by Deployment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Wearable Devices
    • 4.1.2 Implantable Devices
    • 4.1.3 Ingestible Devices
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Sensors
    • 4.2.2 Monitors
    • 4.2.3 Transmitters
    • 4.2.4 Receivers
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Remote Monitoring
    • 4.3.2 Consultation Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Integration Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Bluetooth
    • 4.4.2 Wi-Fi
    • 4.4.3 Zigbee
    • 4.4.4 Ultra-Wideband
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Microcontrollers
    • 4.5.2 Memory Chips
    • 4.5.3 Analog Components
    • 4.5.4 Power Management Units
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Chronic Disease Management
    • 4.6.2 Fitness Monitoring
    • 4.6.3 Remote Patient Monitoring
    • 4.6.4 Post-Acute Care Monitoring
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Ambulatory Surgical Centers
    • 4.7.3 Home Care Settings
    • 4.7.4 Research Institutes
  • 4.8 Market Size & Forecast by Device (2020-2035)
    • 4.8.1 ECG Monitoring Devices
    • 4.8.2 Blood Pressure Monitors
    • 4.8.3 Glucose Monitoring Devices
    • 4.8.4 Pulse Oximeters
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Real-Time Monitoring
    • 4.9.2 Data Logging
    • 4.9.3 Alerts and Notifications
    • 4.9.4 Data Analysis
  • 4.10 Market Size & Forecast by Deployment (2020-2035)
    • 4.10.1 On-Premises
    • 4.10.2 Cloud-Based
    • 4.10.3 Hybrid

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Device
      • 5.2.1.9 Functionality
      • 5.2.1.10 Deployment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Device
      • 5.2.2.9 Functionality
      • 5.2.2.10 Deployment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Device
      • 5.2.3.9 Functionality
      • 5.2.3.10 Deployment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Device
      • 5.3.1.9 Functionality
      • 5.3.1.10 Deployment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Device
      • 5.3.2.9 Functionality
      • 5.3.2.10 Deployment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Device
      • 5.3.3.9 Functionality
      • 5.3.3.10 Deployment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Device
      • 5.4.1.9 Functionality
      • 5.4.1.10 Deployment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Device
      • 5.4.2.9 Functionality
      • 5.4.2.10 Deployment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Device
      • 5.4.3.9 Functionality
      • 5.4.3.10 Deployment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Device
      • 5.4.4.9 Functionality
      • 5.4.4.10 Deployment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Device
      • 5.4.5.9 Functionality
      • 5.4.5.10 Deployment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Device
      • 5.4.6.9 Functionality
      • 5.4.6.10 Deployment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Device
      • 5.4.7.9 Functionality
      • 5.4.7.10 Deployment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Device
      • 5.5.1.9 Functionality
      • 5.5.1.10 Deployment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Device
      • 5.5.2.9 Functionality
      • 5.5.2.10 Deployment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Device
      • 5.5.3.9 Functionality
      • 5.5.3.10 Deployment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Device
      • 5.5.4.9 Functionality
      • 5.5.4.10 Deployment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Device
      • 5.5.5.9 Functionality
      • 5.5.5.10 Deployment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Device
      • 5.5.6.9 Functionality
      • 5.5.6.10 Deployment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Device
      • 5.6.1.9 Functionality
      • 5.6.1.10 Deployment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Device
      • 5.6.2.9 Functionality
      • 5.6.2.10 Deployment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Device
      • 5.6.3.9 Functionality
      • 5.6.3.10 Deployment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Device
      • 5.6.4.9 Functionality
      • 5.6.4.10 Deployment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Device
      • 5.6.5.9 Functionality
      • 5.6.5.10 Deployment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Biotronik
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Medtronic
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Boston Scientific
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 GE Healthcare
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Philips Healthcare
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Siemens Healthineers
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Fujifilm Holdings
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Johnson Johnson Medical Devices
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Stryker
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Zimmer Biomet
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Smith Nephew
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Baxter International
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Becton Dickinson
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Integra Life Sciences
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Hill- Rom Holdings
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Terumo Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Cardinal Health
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Cook Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Nihon Kohden
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제